Relmada Therapeutics
RLMD
RLMD
50 hedge funds and large institutions have $3.18M invested in Relmada Therapeutics in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Holders
50
Holding in Top 10
–
Calls
$15K
Puts
–
Top Buyers
| 1 | +$444K | |
| 2 | +$120K | |
| 3 | +$92.7K | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$78K |
| 5 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$72K |
Top Sellers
| 1 | -$506K | |
| 2 | -$364K | |
| 3 | -$158K | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$134K |
| 5 |
Two Sigma Investments
New York
|
-$45.1K |
